Fidelity Investments
FLXN

Fidelity Investments’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Fidelity Investments’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-50
Closed -$1K – 4746
2020
Q4 		$1K Buy
+50
New +$581 ﹤0.01% 3774
2020
Q3 		– Sell
-675
Closed -$9K – 4144
2020
Q2 		$9K Buy
+675
New +$7K ﹤0.01% 3150
2018
Q4 		– Sell
-131,531
Closed -$2.46M – 4349
2018
Q3 		$2.46M Buy
131,531
+31
+0% +$712 ﹤0.01% 2326
2018
Q2 		$3.4M Hold
131,500
– – ﹤0.01% 2233
2018
Q1 		$2.95M Sell
131,500
-111,800
-46% -$2.73M ﹤0.01% 2296
2017
Q4 		$6.09M Buy
+243,300
New +$5.96M ﹤0.01% 2111
2015
Q1 		– Sell
-1,303,587
Closed -$26.3M – 2815
2014
Q4 		$26.3M Buy
+1,303,587
New +$23.6M ﹤0.01% 1620
2014
Q2 		– Sell
-170,606
Closed -$2.81M – 2818
2014
Q1 		$2.81M Buy
+170,606
New +$2.95M ﹤0.01% 2316

Other funds holding FLXN

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $61.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
CC
Clearline Capital New York $1.29B AUM 38.13% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return